May 2, 2013
CYCLOSET (bromocriptine mesylate) Included in American Association of Clinical Endocrinologists Comprehensive Diabetes Management Algorithm

March 6, 2013
Santarus and VeroScience Announce Publication of AACE Expert Panel Recommendations for CYCLOSET® (bromocriptine mesylate) for the Management of Type 2 Diabetes

January 23, 2013 Santarus and VeroScience Announce Publication of Positive Data from Pivotal CYCLOSET® (bromocriptine mesylate) Efficacy Study

November 13, 2012 Santarus and VeroScience Announce Publication of New Analysis of CYCLOSET (bromocriptine mesylate) Cardiovascular Data in the Journal of the American Heart Association

November 4, 2010 Cycloset Data to Be Presented in Poster Session at 8th Annual World Congress on Insulin Resistance, Diabetes & CVD

September 8, 2010
Santarus Licenses Novel Type 2 Diabetes Drug CYCLOSET

Clinical Studies
Doctor Info
White Papers

Secure Login

• Home
• About
  VeroScience
  • Executive Team
• Drug
  Development
• Development Partners
• Publications & Research
• Contact Us